These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22487193)

  • 1. Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk.
    Ozel C; Seidel J; Meyer-Staeckling S; Brandt BH; Niggemann B; Zänker KS; Dittmar T
    Cell Commun Signal; 2012 Apr; 10(1):10. PubMed ID: 22487193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells.
    Dittmar T; Schwitalla S; Seidel J; Haverkampf S; Reith G; Meyer-Staeckling S; Brandt BH; Niggemann B; Zänker KS
    Clin Exp Metastasis; 2011 Jan; 28(1):75-90. PubMed ID: 20981475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial × Breast Cancer Hybrids, but Not in Parental Cells.
    Fried S; Tosun S; Troost G; Keil S; Zaenker KS; Dittmar T
    PLoS One; 2016; 11(2):e0148438. PubMed ID: 26863029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties.
    Fahlbusch SS; Keil S; Epplen JT; Zänker KS; Dittmar T
    BMC Cancer; 2020 May; 20(1):446. PubMed ID: 32430004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells.
    Gauck D; Keil S; Niggemann B; Zänker KS; Dittmar T
    BMC Cancer; 2017 Aug; 17(1):515. PubMed ID: 28768501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell lines.
    Berndt B; Haverkampf S; Reith G; Keil S; Niggemann B; Zänker KS; Dittmar T
    PLoS One; 2013; 8(5):e63711. PubMed ID: 23667660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid Cells Derived from Human Breast Cancer Cells and Human Breast Epithelial Cells Exhibit Differential TLR4 and TLR9 Signaling.
    Tosun S; Fried S; Niggemann B; Zänker KS; Dittmar T
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
    Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
    Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Koch A; Evers BM
    Anticancer Res; 2010 Dec; 30(12):4951-8. PubMed ID: 21187475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells.
    Romano D; Pertuit M; Rasolonjanahary R; Barnier JV; Magalon K; Enjalbert A; Gerard C
    Endocrinology; 2006 Dec; 147(12):6036-45. PubMed ID: 16935846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
    Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Evers BM
    J Surg Res; 2012 Aug; 176(2):542-8. PubMed ID: 22261591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion.
    Zhou J; Du T; Li B; Rong Y; Verkhratsky A; Peng L
    ASN Neuro; 2015; 7(5):. PubMed ID: 26442853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration.
    Chen D; Xia Y; Zuo K; Wang Y; Zhang S; Kuang D; Duan Y; Zhao X; Wang G
    Sci Rep; 2015 Nov; 5():16813. PubMed ID: 26578388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 (MMP9) is involved in the TNF-α-induced fusion of human M13SV1-Cre breast epithelial cells and human MDA-MB-435-pFDR1 cancer cells.
    Weiler J; Mohr M; Zänker KS; Dittmar T
    Cell Commun Signal; 2018 Apr; 16(1):14. PubMed ID: 29636110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Rac1-PI3K/Akt is required for epidermal growth factor-induced PAK1 activation and cell migration in MDA-MB-231 breast cancer cells.
    Yang Y; Du J; Hu Z; Liu J; Tian Y; Zhu Y; Wang L; Gu L
    J Biomed Res; 2011 Jul; 25(4):237-45. PubMed ID: 23554696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis.
    Fritsche-Guenther R; Witzel F; Kempa S; Brummer T; Sers C; Blüthgen N
    Oncotarget; 2016 Feb; 7(7):7960-9. PubMed ID: 26799289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin β1, myosin light chain kinase and myosin IIA are required for activation of PI3K-AKT signaling following MEK inhibition in metastatic triple negative breast cancer.
    Choi C; Kwon J; Lim S; Helfman DM
    Oncotarget; 2016 Sep; 7(39):63466-63487. PubMed ID: 27563827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.